Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal Truncated α-Synuclein

被引:80
作者
Games, Dora [1 ]
Seubert, Peter [1 ]
Rockenstein, Edward [2 ]
Patrick, Christina [2 ]
Trejo, Margarita [2 ]
Ubhi, Kiren [2 ]
Ettle, Benjamin [5 ]
Ghassemiam, Majid [3 ]
Barbour, Robin [1 ]
Schenk, Dale [1 ]
Nuber, Silke [2 ]
Masliah, Eliezer [2 ,4 ]
机构
[1] Neotope Biosci, San Francisco, CA USA
[2] Univ Calif San Diego, Dept Neurosci, Biomol & Prote Mass Spectrometry Facil, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Chem & Biochem, Biomol & Prote Mass Spectrometry Facil, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Pathol, Biomol & Prote Mass Spectrometry Facil, La Jolla, CA 92093 USA
[5] Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany
关键词
PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODEL; AXONAL-TRANSPORT; BODIES; MICE; DEMENTIA; AGGREGATION; CLEAVAGE; CALPAIN;
D O I
10.1016/j.ajpath.2012.11.018
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Progressive accumulation of alpha-synuclein (alpha-syn) in Limbic and striatonigral systems is associated with the neurodegenerative processes in dementia with Lewy bodies (DLB) and Parkinson's disease (PD). The mutine Thy-1 (mThy1)-alpha-syn transgenic (tg) model recapitulates aspects of degenerative processes associated with a-syn accumulation in these disorders. Given that axonal and synaptic pathologies are important features of DLB and PD, we sought to investigate the extent and characteristics of these alterations in mThy1-alpha-syn tg mice and to determine the contribution of alpha-syn c-terminally cleaved at amino acid 122 (CT alpha-syn) to these abnormalities. We generated a novel polyclonal antibody (SYN105) against the c-terminally truncated sequence (amino acids 121 to 123) of alpha-syn (CT alpha-syn) and performed immunocytochemical and ultrastructural analyses in mThy1-alpha-syn tg mice. We found abundant clusters of dystrophic neurites in Layers 2 to 3 of the neocortex, the stratum Lacunosum, the dentate gyrus, and cornu ammonis 3 of the hippocampus, striatum, thalamus, midbrain, and pons. Dystrophic neurites displayed intense immunoreactivity detected with the SYN105 antibody. Double-labeling studies with antibodies to phosphorylated neurofilaments confirmed the axonal Location of full-Length and CT alpha-syn. alpha-Syn immunoreactive dystrophic neurites contained numerous electrodense laminated structures. These results show that neuritic dystrophy is a prominent pathologic feature of the mThy1-alpha-syn tg model and suggest that CT alpha-syn might play an important role in the process of axonal damage in these mice as well as in DLB and PD. (Am J Pathol 2013, 182: 940-953; http://dx.doi.org/10.1016/j.ajpath.2012.11.018)
引用
收藏
页码:940 / 953
页数:14
相关论文
共 70 条
  • [1] Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
    Anderson, John P.
    Walker, Donald E.
    Goldstein, Jason M.
    de laat, Rian
    Banducci, Kelly
    Caccavello, Russell J.
    Barbour, Robin
    Huang, Jiping
    Kling, Kristin
    Lee, Michael
    Diep, Linnea
    Keim, Pamela S.
    Shen, Xiaofeng
    Chataway, Tim
    Schlossmacher, Michael G.
    Seubert, Peter
    Schenk, Dale
    Sinha, Sukanto
    Gai, Wei Ping
    Chilcote, Tamie J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) : 29739 - 29752
  • [2] Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
    Cali, Tito
    Ottolini, Denis
    Brini, Marisa
    [J]. BIOFACTORS, 2011, 37 (03) : 228 - 240
  • [3] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [4] α-synuclein alters notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice
    Crews, Leslie
    Mizuno, Hideya
    Desplats, Paula
    Rockenstein, Edward
    Adame, Anthony
    Patrick, Christina
    Winner, Beate
    Winkler, Juergen
    Masliah, Eliezer
    [J]. JOURNAL OF NEUROSCIENCE, 2008, 28 (16) : 4250 - 4260
  • [5] Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons
    Daher, Joao Paulo L.
    Ying, Mingyao
    Banerjee, Rebecca
    McDonald, Rebecca S.
    Hahn, Myriam Dumas
    Yang, Lichuan
    Beal, M. Flint
    Thomas, Bobby
    Dawson, Valina L.
    Dawson, Ted M.
    Moore, Darren J.
    [J]. MOLECULAR NEURODEGENERATION, 2009, 4
  • [6] Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1
  • [7] Duda JE, 2003, ANN NY ACAD SCI, V991, P295
  • [8] Calpain-cleavage of α-synuclein -: Connecting proteolytic processing to disease-linked aggregation
    Dufty, Brian M.
    Warner, Lisa R.
    Hou, Sheng T.
    Jiang, Susan X.
    Gomez-Isla, Teresa
    Leenhouts, Kristen M.
    Oxford, Julia T.
    Feany, Mel B.
    Masliah, Eliezer
    Rohn, Troy T.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (05) : 1725 - 1738
  • [9] Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein
    Fleming, S. M.
    Salcedo, J.
    Hutson, C. B.
    Rockenstein, E.
    Masliah, E.
    Levine, M. S.
    Chesselet, M. -F.
    [J]. NEUROSCIENCE, 2006, 142 (04) : 1245 - 1253
  • [10] Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
    Fleming, SM
    Salcedo, J
    Fernagut, PO
    Rockenstein, E
    Masliah, E
    Levine, MS
    Chesselet, MF
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (42) : 9434 - 9440